Introduction {#Sec1}
============

In recent years, endogenous carbon monoxide (CO) production has been shown to play a critical role during inflammatory processes \[[@CR1]--[@CR4]\]. In line with this, exhaled CO has been found to be increased in critically ill patients \[[@CR5]--[@CR7]\], and thus may be used as a diagnostic or monitoring tool. We and others have previously shown that high inspired oxygen concentrations, that are often used during mechanical ventilation in these patients, increase exhaled CO concentrations \[[@CR8], [@CR9]\] and may therefore interfere with exhaled CO measurements. Since oxygen and CO compete for identical haemoglobin binding sites \[[@CR10]\] and this competition occurs in the vascular rather than the alveolar compartment, we hypothesize that the oxygen-induced displacement of CO from haemoglobin largely depends on pulmonary capillary rather than alveolar oxygen tension. Pulmonary capillary oxygen tension is inaccessible to clinical measurements and arterial oxygen tension (PaO~2~) is often used as a surrogate. However, especially in the critically ill, PaO~2~ may not be predicted from FiO~2~ due to altered gas diffusion through the alveolo-capillary membrane and widely scattered ventilation-perfusion ratios as part of inflammatory pulmonary diseases. Therefore, this study in 19 patients scheduled for cardiac surgery was based on the hypothesis that PaO~2~ rather than the FiO~2~ may correlate with exhaled CO levels.

Methods and Materials {#Sec2}
=====================

After approval by the Institutional Review Board and informed consent, patients scheduled for cardiac surgery (*n* = 19, Table [1](#Tab1){ref-type="table"}) were routinely instrumented preoperatively with arterial lines. Among the patients were two current smokers who were abstinent for more than 12 hours prior to surgery. Table 1Demographic data (mean ±SD)Gender (female/male)3 female/16 maleAge (years)69.9 ±7.5Height (cm)171.5 ±8.5Weight (kg)83.3 ± 12.7Baseline haemoglobin (g dl^−1^)12.1 ±1.3Baseline arterial P~a~D~2~ (kPa)11.5 ± 1.9Baseline arterial P~a~C0~2~ (kPa)5.1 ±0.5

Measurements {#Sec3}
------------

End-expiratory CO (eCO in parts per million, ppm) concentrations were measured with an electrochemical analyzer (microPac, Dräger, Lübeck, Germany) with a sampling rate of 0.5 Hz. According to the manufacturer's specifications CO is measured in a range from 0 to 400 ppm with a reproducibility of ( 3%). In order to obtain samples of end-expiratory gas at room air patients were asked to exhale slowly from total lung capacity to expiratory reserve volume over a period of approximately 20 seconds into a disposable mouthpiece connected to the analyzer via a 30 cm hose. At the end of expiration gas flow ceased and the end-expiratory gas remaining in the hose (volume 5.9 ml) served as the sample for determination of alveolar CO concentrations. Technical aspects of the measurements including time-course and reproducibility have been described in detail previously and we have shown that a stable alveolar plateau is reached during expiration \[[@CR8]\]. This plateau value was defined as endexpiratory carbon monoxide concentration.

All measurements were performed in a non-smoking area (operating theatre). Before each measurement, ambient CO levels as well as CO concentrations within the oxygen reservoir were measured to exclude exogenous CO sources.

Arterial oxygen tension (PaO~2~) and arterial carboxyhaemoglobin levels (CO-Hb) were measured using a standard clinical blood gas analyzer (ABL 725, Radiometer, Copenhagen, Denmark).

Study protocol {#Sec4}
--------------

Baseline measurements of eCO, PaO~2~, CO-Hb were performed after patients have been rested for 10 minutes in a supine position. Subsequently, patients breathed oxygen via a tightly fitting face mask for 5 minutes until expiratory oxygen fraction was above 0.9 in all patients excluding dilution of alveolar gas by residual nitrogen. Then, all measurements were repeated as described above.

Statistics {#Sec5}
----------

Data are presented as mean ± standard deviation. Differences between values obtained during air and oxygen breathing were analyzed by two-tailed, paired t-test (Prism 4.0 statistical package, GraphPad Software, San Diego, CA, USA). Correlations were calculated using Pearson's correlation coefficient (r^2^). A *p* \< 0.05 was considered statistically significant.

Results {#Sec6}
=======

Oxygen inhalation resulted in an increase in PaO~2~ from 11.5 ± 1.9 to 35.2 ± 10.3 kPa (*p* \< 0.001, Figure [1a](#Fig1){ref-type="fig"}), as well as an increase in eCO levels from 8.6 ± 4.9 to 16.7 ± 9.4 ppm (*p* \< 0.001, Figure [1b](#Fig1){ref-type="fig"}). As shown in Figure [2](#Fig2){ref-type="fig"} the increase in PaO~2~ was associated with an increase in eCO in all patients with exception of one patient in which eCO levels remained constant. The mean increase in eCO per increase in PaO~2~ (ΔeCO/ΔPaO~2~) was 0.36 ± 0.28 ppm/kPa with a significant correlation between these two parameters (r^2^ = 0.33, *p* \< 0.01). Moreover, while eCO increased, arterial carboxyhaemoglobin concentrations decreased from baseline values of 1.06 ± 0.37 during air breathing to 0.92 ± 0.35 % while inhalation of oxygen (*p* \< 0.001, Figure [3](#Fig3){ref-type="fig"}). ECO concentrations did not correlate with arterial carboxyhaemoglobin concentrations (*P* = 0.83). Fig. 1Arterial oxygen tensions (PaO~2~, Figure 1a) and end-expiratory carbon monoxide concentrations (eCO, Figure 1b) of patients (n = 19, individual values and mean ± SD, ⋆ \< 0.001) while breathing air (open circles) and oxygen (closed circles). Open and closed circles representing the same patient are connected by a line.Fig. 2Arterial oxygen tension (PaO~2~) and corresponding end-expiratory carbon monoxide concentration (eCO) of patients (n = 19) while breathing air (open circles) and oxygen (closed circles). Open and closed circles representing the same patient are connected by a line. The mean slope corresponding to the mean increase in end-expiratory CO concentration per kPa increase in PaO~2~ (ΔeCO/ΔPaO~2~) is 0.36.Fig. 3Arterial carboxyhaemoglobin (CO-Hb) and end-expiratory carbon monoxide concentration (eCO) of patients (n = 19, mean ± SEM) while breathing air (open circles) and oxygen (closed circles).

Discussion {#Sec7}
==========

Exhaled carbon monoxide originates from exogenous (ambient CO) and endogenous sources. Endogenous CO production is mainly due to degradation of haeme and the first and rate-limiting step of this metabolic pathway is catalyzed by microsomal haeme oxygenase \[[@CR1]--[@CR3], [@CR11]\]. Of the three known isoforms, haeme oxygenase-1 is inducible by oxidative stress and, therefore, elevated exhaled carbon monoxide levels were suggested to be a noninvasive marker of local airway and systemic inflammation \[[@CR5]--[@CR7], [@CR12]--[@CR15]\]. Moreover, elevated expiratory CO concentrations may be of diagnostic value in patients with suspected carbon monoxide intoxication \[[@CR16]\]. Since critically ill patients as well as patients with inflammation or intoxication are often treated with oxygen, awareness of effects of oxygen inhalation on expiratory and blood CO concentrations may be helpful in the interpretation of the obtained measurements.

We measured exhaled carbon monoxide concentrations in patients in supine position breathing room air or oxygen. CO concentrations were quantified with an electrochemical analyzer as described previously \[[@CR8]\]. The last portions of the exhaled gas represented samples of alveolar air and were defined as endexpiratory CO concentrations. All measurements were performed in a non-smoking area. In addition, we determined CO concentrations in the ambient air to ensure that all measured CO represented endogenous carbon monoxide of the patients. During inhalation of oxygen, we measured in- as well as expiratory oxygen concentrations to exclude that the alveolar gas was diluted by residual or co-inspired nitrogen. Endexpiratory oxygen fractions corresponding to alveolar fractions were above 0.9 in all patients.

It is well established that oxygen competes with CO for the same haemoglobin binding sites, which is the basis for treating CO intoxications by inhalation of high oxygen concentrations. Indeed, we and others have recently demonstrated that increases in inspiratory oxygen fractions are associated with an increase in exhaled CO levels \[[@CR8], [@CR9]\]. However, this may only be valid for lung regions with a normal pulmonary gas exchange through the alveolarcapillary membrane, i.e. a ventilation-to-perfusion ratio close to 1. Accordingly, ventilation-perfusion mismatch, as it occurs during lung diseases such as COPD (increased dead-space ventilation) or the acute respiratory distress syndrome (increased intrapulmonary shunting), may result in both impaired oxygen uptake and CO excretion through the lungs. Therefore, we hypothesized that increases in exhaled CO levels may correlate with increases in arterial oxygen tensions (PaO~2~). Indeed, breathing oxygen through a tightly fitted face mask caused an increase in PaO~2~ in all patients. On the basis of a wide range of oxygen-induced changes in PaO~2~ (3.7 to 42.8 kPa) in our patients, we found that increases in PaO~2~ significantly correlated with increases in eCO. Moreover, we demonstrated oxygen inhalation to reduce CO-Hb levels, supporting the concept of accelerated CO elimination by oxygen via the lungs. In accordance to our findings, Weaver et al. observed in a retrospective analysis in patients an inverse correlation between arterial oxygen tension and carboxyhaemoglobin half-life and thus increased elimination \[[@CR17]\]. However, Weaver et al. studied changes in blood CO levels during continuous O~2~ breathing, not during acute PaO~2~ changes. Our study aimed to investigate the relationship between acute changes in PaO~2~ and changes in endexpiratory CO concentration. To the best of our knowledge, the data show for the first time prospectively a correlation between ΔeCO and ΔPaO~2~. While our data suggest that eCO levels obtained in acutely ill patients receiving oxygen therapy may be erroneously high because of a high PaO~2~ it must be emphasized that these data only apply to acute changes of PaO~2~. However, patients may be treated with higher inspiratory oxygen concentrations for a longer period of time and it seems unlikely that acute eCO changes in this study can reliably represent stable eCO levels during hours of oxygen therapy. Thus our data may only serve as a qualitative advisory but do not allow estimations of PaO~2~)adjusted eCO concentrations. Moreover, we did not find a correlation between eCO concentrations and arterial CO-Hb levels, so that CO-Hb concentrations may not be estimated from eCO concentrations. Further work is needed to determine the value of measuring eCO in acutely ill patients, and/or CO intoxicated patients, and the best procedures for these clinical scenarios.

In summary, our study demonstrates that oxygen-induced increases in exhaled CO correlate with increases in arterial oxygen tensions. This is likely explained by an accelerated carbon monoxide elimination during lung passage.
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